News

BMJ1d
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells
Department of Medicine, Division of Respiratory Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden Dr A I Catrina, Rheumatology ...
BMJ2d
Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale
OBJECTIVE To assess organ involvement according to a modified Medsger severity scale and its relation to outcome and prognosis in patients with systemic sclerosis. METHODS One hundred consecutive ...
BMJ2d
A disease activity score for polymyalgia rheumatica
Objective: To develop a composite score for measurement of disease activity in polymyalgia rheumatica (PMR) and assess its internal and external validity. Methods: A PMR activity score (AS) was ...
BMJ2d
Prognostic laboratory markers of joint damage in rheumatoid arthritis
Objective: To investigate whether determination of a set of laboratory markers at baseline provides prognostic information on joint damage in hands and feet in rheumatoid arthritis. Methods: 183 ...
BMJ3d
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
Background An important but often insufficient aspect of care in people with inflammatory arthritis (IA) is empowering patients to acquire a good understanding of their disease and building their ...
BMJ3d
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis
Objectives Clinical heterogeneity is a cardinal feature of systemic sclerosis (SSc). Hallmark SSc autoantibodies are central to diagnosis and associate with distinct patterns of skin-based and ...
BMJ4d
Increased mortality in ankylosing spondylitis is related to disease activity
1 Department of Rheumatology, University Hospital of Northern Norway, Tromsø, Norway 2 Department of Rheumatology, Rikshospitalet-Radiumhospitalet University Hospital, Oslo, Norway Correspondence to ...
BMJ4d
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
1 Department of Rheumatology, Chinese PLA General Hospital, Beijing, People's Republic of China 2 Department of Rheumatology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's ...
BMJ4d
Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis
Objective To identify predictors of poorer physical function in established psoriatic arthritis (PsA). Methods PsA patients with disease duration of ≥10 years were identified from the Bath ...
BMJ4d
Six months open label trial of leflunomide in active ankylosing spondylitis
Objective: To examine the potential therapeutic effects of leflunomide in patients with active AS in an open label study. Patients and methods: Twenty patients with AS fulfilling the 1984 modified New ...
BMJ4d
Open label trial of anakinra in active ankylosing spondylitis over 24 weeks
Objective: To examine the therapeutic effect of the interleukin 1 (IL1) receptor antagonist anakinra in ankylosing spondylitis in an open label trial. Methods: Anakinra (100 mg) was given ...
BMJ4d
Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series
Correspondence to Dr Adi Diab, Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center FC3004, 1515 Holcombe Blvd Houston, Texas; adiab{at}mdanderson.org Background Immune ...